H. Vestergaard et al., INSULIN-RESISTANT GLUCOSE-METABOLISM IN PATIENTS WITH MICROVASCULAR ANGINA - SYNDROME-X, Metabolism, clinical and experimental, 44(7), 1995, pp. 876-882
Studies in patients with microvascular angina (MA) or the cardiologic
syndrome X have shown a hyperinsulinemic response to an oral glucose c
hallenge, suggesting insulin resistance and a role for increased serum
insulin in coronary microvascular dysfunction. The aim of the present
study was to examine whether patients with MA are insulin resistant.
Nine patients with MA and seven control subjects were studied. All wer
e sedentary and glucose-tolerant. Coronary arteriography was normal in
all participants, and exercise-induced coronary ischemia was demonstr
ated in all MA patients. A euglycemic. hyperinsulinemic clamp was perf
ormed in combination with indirect calorimetry. Biopsy of vastus later
alis muscle was taken in the basal state and after 4 hours of euglycem
ia and hyperinsulinemia (2 mU . kg(-1). min(-1)). The fasting level of
''true'' serum insulin was significantly higher (43 +/- 6 v 22 +/- 3
pmol/L, P +/- .02) and the rate of insulin-stimulated glucose disposal
to peripheral tissues was lower in patients with MA (13.4 +/- 1.0 v 1
8.2 +/- 1.4 mg . kg fat-free mass [FFM](-1). min(-1), P < .02) due to
a decrease in nonoxidative glucose metabolism (8.4 +/- 0.9 v 12.5 +/-
1.3 mg . kg FFM(-1). min(-1), P < .02). No difference was found in glu
cose or lipid oxidation rates between the two groups. In patients with
MA, as well as in the pooled group of all participants, a positive co
rrelation was demonstrated between the insulin-stimulated increment in
fractional activity of skeletal muscle glycogen synthase (GS) and the
increment in nonoxidative glucose metabolism after in vivo insulin ex
posure (MA: r = .73, P = .03; all participants: r = .73, P = .005), in
dicating a reduced in vivo activation of GS in MA patients. In conclus
ion, (1) MA is part of the insulin resistance syndrome, and (2) the in
sulin resistance is predominantly localized to the glycogen synthesis
pathway in skeletal muscle tissue. Copyright (C) 1995 by W.B. Saunders
Company